文献速递血栓与止血

首例IgM型单克隆抗体导致αIIbβ3整合素活化并伴巨血小板减少的获得性Glanzmann血小板无力症

First description of an IgM monoclonal antibody causing αIIb β3 integrin activation and acquired Glanzmann thrombasthenia associated with macrothrombocytopenia.
PubMed 文献 · J Thromb Haemost · 2019-04-19

本文报道一例慢性免疫性血小板减少症患者出现进行性Glanzmann血小板无力症样表型,伴巨血小板减少。患者血浆中IgM型自身抗体与αIIbβ3结合并激活该整合素,触发外向信号传导,同时患者血清可显著减少对照骨髓干细胞培养中产前血小板的巨核细胞数量。

要点

  • 获得性Glanzmann血小板无力症通常由抗αIIbβ3自身抗体引起,本例为IgM型活化性自身抗体。
  • 患者IgM结合正常血小板但不结合I型Glanzmann血小板无力症患者血小板,血浆可激活对照血小板αIIbβ3。
  • 患者血清显著减少对照骨髓干细胞培养中产前血小板巨核细胞数量。

核心结论

  • 本文报道一例进行性严重血小板功能紊乱患者,其血浆中存在针对αIIbβ3的IgM活化性自身抗体。

研究设计与样本

  • 本文为单例病例报告,患者为一名患有慢性免疫性血小板减少症的男性。

主要发现

  • 患者反复发生胃肠道出血,进一步检查提示中度血小板聚集缺陷;数月后所有激动剂诱导的血小板聚集均消失,但利托菌素凝集正常。
  • 患者渗透化血小板中检测到大量IgM型抗体与αIIbβ3共同存在,未检测到血小板结合抗体。
  • 患者IgM结合正常血小板但不结合I型Glanzmann血小板无力症患者血小板;患者血浆使对照血小板PAC-1结合增加,提示αIIbβ3活化。
  • 患者血浆触发αIIbβ3外向信号传导,β3 Tyr773和FAK磷酸化,并增加静息血小板肌动蛋白聚合速率。
  • 患者血清较正常血清显著降低对照骨髓干细胞培养中产前血小板巨核细胞数量。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Essentials Acquired Glanzmann thrombasthenia (GT) is generally caused by anti-αIIb β3 autoantibodies. We report the case of a man with an acquired GT phenotype associated with macrothrombocytopenia. Perturbed platelet function were associated with an activating anti-αIIb β3 IgM autoantibody. This novel clinical entity raises interesting questions about the αIIb β3 integrin signaling. SUMMARY: Background Acquired Glanzmann thrombasthenia (GT) is a bleeding disorder generally caused by anti-αIIb β3 autoantibodies. Objectives We aimed to characterize the molecular mechanism leading to a progressive GT-like phenotype in a patient with chronic immune thrombocytopenia. Patient, Methods, and Results The patient suffered from repeated episodes of gastrointestinal bleeding; further studies indicated a moderate platelet aggregation defect. A few months later, platelet function showed abolished aggregation using all agonists, but normal agglutination with ristocetin. No platelet-bound antibodies were detected, but the presence of large amounts of an IgM type antibody detected together with αIIb β3 in the patient permeabilized platelets suggested that this IgM was an autoantibody causing the internalization of the complex. This was confirmed by the fact that the patient IgM bound to normal platelets but not to platelets from GT type I patients. Moreover, patient's plasma activated αIIb β3 on controls' platelets as evidenced by increased PAC-1 binding. We also demonstrated that the patient plasma triggered αIIb β3 outside-in signaling, as β3 Tyr773 and FAK were phosphorylated, and increased the rate of actin polymerization in resting platelets reflecting an impairment of cytoskeletal reorganization. Because different signs of dysmegakaryopoiesis were also observed in our patient, we evaluated the ability of its serum to impair proplatelets formation and showed that it significantly decreased the number of proplatelet-bearing megakaryocytes in controls' bone marrow stem cells culture compared with normal serum. Conclusions We present the case of a patient with a progressive and severely perturbed platelet function associated with the presence of an IgM activating autoantibody directed against αIIb β3 .

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Pillois X, Guy A, Choquet É, et al. First description of an IgM monoclonal antibody causing αIIb β3 integrin activation and acquired Glanzmann thrombasthenia associated with macrothrombocytopenia. J Thromb Haemost. 2019. PMID: 30868743. doi:10.1111/jth.14424

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。